Schedule 13G ownership disclosure

INOTEK PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 45780V102

Event date: 2017-09-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-17-036028
Form type
SC 13G
Filer
BML Investment Partners, L.P.
CIK
CIK 1373604
Filed
Sep 20, 2017
Reporting period
Sep 13, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub